Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Trimel Pharmaceuticals Current Ratio 2012-2020 | ASPCF

For a detailed definition, formula and example for Current Ratio, check out our new background page here.
Trimel Pharmaceuticals current ratio from 2012 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
  
Trimel Pharmaceuticals Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-09-30 $0.01B $0.01B 1.30
2020-06-30 $0.02B $0.01B 2.43
2020-03-31 $0.02B $0.01B 2.94
2019-12-31 $0.01B $0.01B 1.23
2019-09-30 $0.01B $0.01B 0.89
2019-06-30 $0.01B $0.01B 0.74
2019-03-31 $0.01B $0.01B 1.16
2018-12-31 $0.01B $0.01B 1.35
2018-09-30 $0.01B $0.01B 0.69
2018-06-30 $0.01B $0.01B 1.01
2018-03-31 $0.01B $0.01B 0.95
2017-12-31 $0.01B $0.00B 1.95
2017-09-30 $0.01B $0.00B 1.62
2017-06-30 $0.01B $0.00B 1.81
2017-03-31 $0.01B $0.00B 1.97
2016-12-31 $0.01B $0.01B 1.70
2016-09-30 $0.02B $0.01B 1.75
2016-06-30 $0.02B $0.01B 1.87
2016-03-31 $0.01B $0.02B 0.53
2015-12-31 $0.01B $0.03B 0.47
2015-09-30 $0.03B $0.01B 2.19
2015-06-30 $0.03B $0.01B 2.70
2015-03-31 $0.03B $0.01B 3.38
2014-12-31 $0.04B $0.01B 3.17
2014-09-30 $0.02B $0.01B 2.15
2014-06-30 $0.02B $0.01B 1.97
2014-03-31 $0.02B $0.01B 2.94
2013-12-31 $0.02B $0.01B 1.70
2013-09-30 $0.03B $0.01B 4.78
2013-06-30 $0.03B $0.01B 4.21
2013-03-31 $0.01B $0.01B 0.49
2012-12-31 $0.01B $0.01B 1.39
2012-09-30 $0.02B $0.01B 2.20
2012-06-30 $0.01B $0.01B 0.76
2012-03-31 $0.01B $0.01B 1.88
2011-12-31 $0.02B $0.00B 3.66
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.060B $0.004B
Acerus Pharmaceuticals Corporation is a pharmaceutical company. The company is focused on the development, manufacture, marketing and distribution of branded products which improve the patient experience. The company's product include ESTRACE(R) which provides symptomatic relief of menopausal symptoms and NATESTO(TM) a bioadhesive intranasal gel formulation of testosterone. It also develops Tefina, an intranasal, low-dose gel formulation of testosterone for women experiencing female orgasmic disorder. Acerus Pharmaceuticals Corp, formerly known as Trimel Pharmaceuticals Corp, is headquartered in Mississauga, Canada.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $75.799B 41.43
Takeda Pharmaceutical (TAK) Japan $54.070B 9.91
Astellas Pharma (ALPMY) Japan $31.315B 19.33
Eisai (ESALY) Japan $21.510B 23.86
Catalent (CTLT) United States $19.202B 50.81
Grifols, S.A (GRFS) Spain $11.063B 12.67
Neurocrine Biosciences (NBIX) United States $10.201B 23.66
Jazz Pharmaceuticals (JAZZ) Ireland $8.773B 14.81
Arrowhead Pharmaceuticals (ARWR) United States $8.485B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.190B 0.00
Ionis Pharmaceuticals (IONS) United States $7.837B 76.78
United Therapeutics (UTHR) United States $7.661B 16.31
IPSEN SA ADR (IPSEY) France $7.134B 0.00
Evotec AG (EVTCY) Germany $6.618B 446.94
Orion OYJ (ORINY) Finland $5.794B 20.11
FibroGen (FGEN) United States $4.666B 0.00
ChemoCentryx (CCXI) United States $4.598B 0.00
Sage Therapeutics (SAGE) United States $4.176B 0.00
Nektar Therapeutics (NKTR) United States $4.042B 0.00
Cronos Group (CRON) Canada $4.010B 0.00
Hypermarcas (HYPMY) Brazil $3.949B 15.59
PTC Therapeutics (PTCT) United States $3.909B 0.00
Tilray (TLRY) Canada $3.310B 0.00
Pacira BioSciences (PCRX) United States $3.299B 71.64
Corcept Therapeutics (CORT) United States $3.093B 31.32
Revolution Medicines (RVMD) United States $2.934B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.802B 17.35
Xencor (XNCR) United States $2.778B 0.00
AlloVir (ALVR) United States $2.527B 0.00
Endo (ENDP) Ireland $2.258B 3.43
Sundial Growers (SNDL) Canada $1.967B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.958B 0.00
USANA Health Sciences (USNA) United States $1.953B 15.84
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.831B 0.00
ImmunoGen (IMGN) United States $1.785B 0.00
Translate Bio (TBIO) United States $1.702B 0.00
Heron Therapeutics (HRTX) United States $1.623B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.518B 12.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.439B 10.00
Organogenesis Holdings (ORGO) United States $1.438B 0.00
Ocular Therapeutix (OCUL) United States $1.422B 0.00
Indivior (INVVY) United States $1.342B 0.00
Zogenix (ZGNX) United States $1.274B 0.00
Trillium Therapeutics (TRIL) Canada $1.230B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.129B 0.00
Karyopharm Therapeutics (KPTI) United States $1.074B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.038B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Aclaris Therapeutics (ACRS) United States $0.902B 0.00
Vectura Group (VEGPF) United Kingdom $0.877B 0.00
Radius Health (RDUS) United States $0.867B 0.00
Collegium Pharmaceutical (COLL) United States $0.848B 50.04
Esperion Therapeutics (ESPR) United States $0.777B 0.00
VAXART, INC (VXRT) United States $0.743B 0.00
Aerie Pharmaceuticals (AERI) United States $0.733B 0.00
Rafael Holdings (RFL) United States $0.703B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.697B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.689B 0.00
Chinook Therapeutics (KDNY) United States $0.650B 0.00
Altimmune (ALT) United States $0.634B 0.00
Ardelyx (ARDX) United States $0.621B 0.00
Acutus Medical (AFIB) United States $0.615B 0.00
KalVista Pharmaceuticals (KALV) United States $0.610B 0.00
Summit Therapeutics (SMMT) United States $0.604B 0.00
Akebia Therapeutics (AKBA) United States $0.597B 0.00
Molecular Templates (MTEM) United States $0.565B 0.00
Flexion Therapeutics (FLXN) United States $0.562B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.533B 0.00
AVITA Medical (RCEL) United States $0.521B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.510B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.507B 0.00
Siga Technologies (SIGA) United States $0.501B 14.06
TherapeuticsMD (TXMD) United States $0.483B 0.00
PROFOUND MEDICL (PROF) Canada $0.473B 0.00
DURECT (DRRX) United States $0.457B 0.00
Harpoon Therapeutics (HARP) United States $0.455B 0.00
MEI Pharma (MEIP) United States $0.449B 0.00
Jounce Therapeutics (JNCE) United States $0.436B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.416B 10.85
VYNE Therapeutics (VYNE) United States $0.411B 0.00
Redhill Biopharma (RDHL) Israel $0.407B 0.00
Innate Pharma SA (IPHYF) France $0.350B 0.00
Nature's Sunshine Products (NATR) United States $0.334B 21.52
CASI Pharmaceuticals (CASI) United States $0.315B 0.00
Onconova Therapeutics (ONTX) United States $0.306B 0.00
Xeris Pharmaceuticals (XERS) United States $0.276B 0.00
Oncternal Therapeutics (ONCT) United States $0.273B 0.00
Alpine Immune Sciences (ALPN) United States $0.270B 0.00
Jaguar Animal Health (JAGX) United States $0.269B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.257B 0.00
Lannett Co Inc (LCI) United States $0.246B 8.24
CTI BioPharma (CTIC) United States $0.242B 0.00
Novan (NOVN) United States $0.241B 0.00
IMV INC (IMV) Canada $0.238B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.232B 0.00
Iterum Therapeutics (ITRM) Ireland $0.228B 0.00
Infinity Pharmaceuticals (INFI) United States $0.218B 0.00
Qilian Holding Group (QLI) China $0.215B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.213B 0.00
OptiNose (OPTN) United States $0.211B 0.00
Concert Pharmaceuticals (CNCE) United States $0.210B 0.00
Calithera Biosciences (CALA) United States $0.209B 0.00
Taiwan Liposome (TLC) Taiwan $0.208B 0.00
Nutriband (NTRB) United States $0.191B 0.00
Heat Biologics (HTBX) United States $0.190B 0.00
KemPharm (KMPH) United States $0.187B 0.00
Aquestive Therapeutics (AQST) United States $0.177B 0.00
IsoRay (ISR) United States $0.174B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.171B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.166B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.164B 0.00
Genocea Biosciences (GNCA) United States $0.161B 0.00
Aziyo Biologics (AZYO) United States $0.159B 0.00
Champions Oncology (CSBR) United States $0.154B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.153B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.151B 0.00
MediWound (MDWD) Israel $0.143B 0.00
Otonomy (OTIC) United States $0.139B 0.00
Lipocine (LPCN) United States $0.134B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.124B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.123B 0.00
Recro Pharma (REPH) United States $0.115B 0.00
ProPhase Labs (PRPH) United States $0.115B 0.00
Assertio Holdings (ASRT) United States $0.104B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.104B 0.00
Natural Alternatives (NAII) United States $0.102B 27.59
Baudax Bio (BXRX) United States $0.101B 0.00
ElectroCore (ECOR) United States $0.096B 0.00
AIM ImmunoTech (AIM) United States $0.092B 0.00
SCYNEXIS (SCYX) United States $0.090B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.086B 0.00
PolarityTE (PTE) United States $0.084B 0.00
India Globalization Capital (IGC) United States $0.083B 0.00
AgeX Therapeutics (AGE) United States $0.081B 0.00
CV Sciences (CVSI) United States $0.076B 0.00
Biomerica (BMRA) United States $0.075B 0.00
Sigyn Therapeutics (SIGY) United States $0.073B 0.00
Inhibikase Therapeutics (IKT) United States $0.070B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.066B 0.00
Brickell Biotech (BBI) United States $0.065B 0.00
Addex Therapeutics (ADXN) Switzerland $0.062B 0.00
Regulus Therapeutics (RGLS) United States $0.058B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.055B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 26.00
NovaBay Pharmaceuticals (NBY) United States $0.049B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.046B 0.00
RXi Pharmaceuticals (PHIO) United States $0.045B 0.00
Neos Therapeutics (NEOS) United States $0.044B 0.00
Mannatech (MTEX) United States $0.038B 5.57
Can-Fite Biopharma (CANF) Israel $0.034B 0.00
Midatech Pharma (MTP) United Kingdom $0.030B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.029B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.023B 0.00
Cyanotech (CYAN) United States $0.021B 17.60
HANCOCK JAFFE (HJLI) United States $0.019B 0.00
China SXT Pharmaceuticals (SXTC) China $0.019B 0.00
Xenetic Biosciences (XBIO) United States $0.017B 0.00
JanOne (JAN) United States $0.017B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Plus Therapeutics (PSTV) United States $0.015B 0.00
SHINECO INC (TYHT) China $0.012B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00